Organogenesis Holdings (ORGO) Cash & Equivalents (QoQ) (2016 - 2026)
Organogenesis Holdings (ORGO) Cash & Equivalents (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Organogenesis Holdings | 241.26 Mn | 194.42 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -49.55% |
| Mar 31, 2026 | -2.46% |
| Dec 31, 2025 | 46.96% |
| Sep 30, 2025 | -12.77% |
| Jun 30, 2025 | -33.55% |
| Mar 31, 2025 | -18.89% |
| Dec 31, 2024 | 43.70% |
| Sep 30, 2024 | 4.94% |
| Jun 30, 2024 | 1.44% |
| Mar 31, 2024 | -14.65% |
| Dec 31, 2023 | 5.72% |
| Sep 30, 2023 | 10.47% |
| Jun 30, 2023 | 0.25% |
| Mar 31, 2023 | -13.45% |
| Dec 31, 2022 | -4.45% |
| Sep 30, 2022 | -4.48% |
| Jun 30, 2022 | 4.06% |
| Mar 31, 2022 | -5.29% |
| Sep 30, 2018 | 0.46% |
| Jun 30, 2018 | 316,324.88% |